Global Genetic Testing Market to Reach US$ 43.1 Billion by 2032, Accelerated by Rising Prevalence of Genetic Disorders and Diseases

July 11, 2023 | Healthcare

As per the latest report by IMARC Group, titled "Genetic Testing Market Report by Type (Predictive and Presymptomatic Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing and Chromosome Analysis, Biochemical Testing, Molecular Testing), Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others), and Region 2024-2032," the global genetic testing market size reached US$ 17.7 Billion in 2023. Genetic testing offers valuable insights into the genetic makeup and involves analyzing deoxyribonucleic acid (DNA) samples to identify variations or mutations that may be associated with specific genetic conditions or predispositions. Samples can be obtained from blood, saliva, or tissue, making the procedure minimally invasive and accessible to a wide range of individuals. Once the samples are collected, they are sent to a laboratory, where advanced techniques, such as polymerase chain reaction (PCR) or next-generation sequencing (NGS), are used to decode the genetic information. Genetic testing allows individuals to assess their risk for developing or passing certain hereditary conditions to their offspring, such as cancer, cardiovascular diseases, or neurological disorders. Additionally, it enables personalized medicine, as it allows healthcare providers to tailor treatments and medications based on an individual's genetic profile, optimizing efficacy and minimizing adverse reactions. Currently, there are several types of genetic testing available, including diagnostic, carrier, predictive, and ancestry testing.

Global Genetic Testing Market Trends:

The global genetic testing market is favored by the increasing prevalence of genetic disorders and diseases and the rising awareness among individuals regarding the benefits of genetic testing. Moreover, rapid advancements in technology, particularly in next-generation sequencing (NGS) and microarray technologies, have led to improved accuracy, speed, and cost-effectiveness of genetic testing, making it more accessible to a wider population. Furthermore, the growing application of genetic testing in oncology, pharmacogenomics, and prenatal screening and supportive government initiatives and favorable reimbursement policies have encouraged the integration of genetic testing into mainstream healthcare systems, which is creating a positive outlook for the market. Besides this, strategic collaborations and partnerships between genetic testing companies and pharmaceutical firms have fueled research and development (R&D) efforts in precision medicine, which is accelerating the market growth. In line with this, the integration of artificial intelligence (AI) and machine learning (ML) algorithms into genetic testing platforms has enhanced data analysis and interpretation, further driving the market growth. Additionally, the increasing adoption of genetic testing by healthcare providers for disease risk assessment, diagnosis, and treatment selection and the expanding biobanking infrastructure are influencing the market growth. Other factors, such as the rising popularity of at-home genetic testing kits, the growing focus on precision medicine, and the shift towards personalized healthcare, are contributing to the market growth. Looking forward, the market value is projected to reach US$ 43.1 Billion by 2032, expanding at a CAGR of 10.1% during 2024-2032.

Market Summary: 

  • By the type, the market is categorized into predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and others.
  • Based on technology, the market is divided into cytogenetic testing and chromosome analysis, biochemical testing, and molecular testing (DNA sequencing and others).
  • By the application, the market is segmented into cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis, and others.
  • On the basis of the region, the market has been categorized into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. 
  • The competitive landscape of the industry has also been examined with some of the key players being 23andme Inc., Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.), Bio-RAD Laboratories Inc., Cepheid (Danaher Corporation), Eurofins Scientific, Illumina Inc., Invitae Corporation, Luminex Corporation (DiaSorin), Myriad Genetics Inc., QIAGEN, Quest Diagnostics and Thermo Fisher Scientific.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Type, Technology, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 23andme Inc., Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.), Bio-RAD Laboratories Inc., Cepheid (Danaher Corporation), Eurofins Scientific, Illumina Inc., Invitae Corporation, Luminex Corporation (DiaSorin), Myriad Genetics Inc., QIAGEN, Quest Diagnostics and Thermo Fisher Scientific.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Genetic Testing Market to Reach US$ 43.1 Billion by 2032, Accelerated by Rising Prevalence of Genetic Disorders and Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More